IBDEI2FO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41276,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,41276,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,41276,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,41277,0)
 ;;=D68.32^^159^2004^84
 ;;^UTILITY(U,$J,358.3,41277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41277,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,41277,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,41277,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,41278,0)
 ;;=C22.2^^159^2004^85
 ;;^UTILITY(U,$J,358.3,41278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41278,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,41278,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,41278,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,41279,0)
 ;;=D58.9^^159^2004^87
 ;;^UTILITY(U,$J,358.3,41279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41279,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,41279,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,41279,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,41280,0)
 ;;=C81.99^^159^2004^88
 ;;^UTILITY(U,$J,358.3,41280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41280,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,41280,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,41280,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,41281,0)
 ;;=C81.90^^159^2004^89
 ;;^UTILITY(U,$J,358.3,41281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41281,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,41281,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,41281,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,41282,0)
 ;;=D89.2^^159^2004^90
 ;;^UTILITY(U,$J,358.3,41282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41282,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,41282,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,41282,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,41283,0)
 ;;=D05.12^^159^2004^91
 ;;^UTILITY(U,$J,358.3,41283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41283,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,41283,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,41283,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,41284,0)
 ;;=D05.11^^159^2004^92
 ;;^UTILITY(U,$J,358.3,41284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41284,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,41284,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,41284,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,41285,0)
 ;;=D05.10^^159^2004^93
 ;;^UTILITY(U,$J,358.3,41285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41285,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,41285,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,41285,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,41286,0)
 ;;=D50.0^^159^2004^94
 ;;^UTILITY(U,$J,358.3,41286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41286,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,41286,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,41286,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,41287,0)
 ;;=D50.9^^159^2004^95
 ;;^UTILITY(U,$J,358.3,41287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41287,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,41287,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,41287,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,41288,0)
 ;;=C46.9^^159^2004^96
 ;;^UTILITY(U,$J,358.3,41288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41288,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,41288,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,41288,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,41289,0)
 ;;=C22.0^^159^2004^97
